Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function

Journal of Orthopaedic Surgery and Research

Zhibiao Wang¹  Zhanhu Mi²  Peng Ye²  Yanyun Dong³ 

[1]Department of Orthopedics, Rizhao Central Hospital, 276000, Rizhao, Shandong, People’s Republic of China

[2]Department of Trauma Orthopedics, General Hospital of Ningxia Medical University, 804 South Shengli Street, 750004, Yinchuan, Ningxia, People’s Republic of China

[3]Operating Room, General Hospital of Ningxia Medical University, 750004, Yinchuan, Ningxia, People’s Republic of China

关键词: Osteosarcoma;    lncRNA GNAS-AS1;    Prognosis;    Proliferation;    Migration;    Invasion;   

DOI  :  10.1186/s13018-021-02611-2

来源: Springer

【 摘 要 】

BackgroundOsteosarcoma (OS) is a type of bone cancer that occurs in children and adolescents at a rate of 5%. The purpose of this study is to explore the lncRNA GNAS-AS1 expression profile, prognosis significance in OS, and biological effect on OS cell function.MethodsOne hundred eight pairs of tissues were collected, and OS cell lines were purchased. lncRNA GNAS-AS1 expression in these tissues and cells were analyzed by qRT-PCR. Clinical data were analyzed using chi-square tests, Kaplan-Meier curves (log-rank test), and Cox regression. CCK-8 and transwell assay were conducted to analyze the effect of lncRNA GNAS-AS1 on cell proliferation, invasion, and migration. The downstream miRNA was presumed.ResultsThe expression of lncRNA GNAS-AS1 was significantly increased in OS cells and tissues, and related to Enneking staging and distant metastasis. Patients with high lncRNA GNAS-AS1 expression represented shorter overall survival and was an independent prognostic predictor of OS. LncRNA GNAS-AS1 knockdown inhibited cell proliferation, migration, and invasion by regulated miR-490-3p partly at least.ConclusionsLncRNA GNAS-AS1 can be used as a prognostic indicator and its inhibition suppress the development of OS, suggesting its value as novel therapeutic strategies in OS.

【 授权许可】

CC BY